MFN: What can we learn from European international reference pricing?
A paper in Value in Health by Grueger, Martin and Sullivan (2025) provides some lessons….
MFN: What can we learn from European international reference pricing?
A paper in Value in Health by Grueger, Martin and Sullivan (2025) provides some lessons. Together with widespread digitalization of drug compendia (price lists), IRP led to a rapid convergence of list prices across Europe. Although prices often spread ±50% from the average price for drugs first launched in the EU in 1997, this narrowed…
Headway Launches Enhanced EHR Platform for Mental Health Providers
Headway has expanded its EHR system to include an AI-assisted notes feature and an integrated telehealth capability. The post Headway Launches Enhanced EHR Platform for Mental Health Providers appeared first on MedCity News.
Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care
The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care. The post Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of…
KFF Health News’ ‘What the Health?’: Countdown to Government Shutdown
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
House Committee on Appropriations Approves FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bill & Accompanying Report
This budget summary provides an analysis of global health funding amounts provided in the House FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.
LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M for Key Schizophrenia Drug Trial
LB Pharmaceuticals found enough investor interest to boost the size of its IPO, which will finance clinical trials in schizophrenia and bipolar depression. The biotech has modified an old Sanofi drug with changes intended to reduce side effects and allow less frequent dosing. The post LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M…
Potential Story Lines from Trump-Era Health Care Cuts
In his latest column for the JAMA Health Forum, KFF’s Larry Levitt talks about how popular shows like “The Pitt” can make changes to the health care system stemming from this year’s federal tax and budget bill tangible for viewers, and offers some suggested story lines.
Healthcare’s Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination
The real story isn’t about denial rates or stakeholders acting as villains. It’s about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos. The post Healthcare’s Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination appeared first on MedCity News.
Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy
The latest episode of the Debunked podcast explored an ongoing debate questioning the role of payers in healthcare transactions. It also highlighted turmoil at the CDC.. The post Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy appeared first on MedCity News.
Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in the Emergency Department
Early diagnostics for acute intoxication in the emergency department are about more than just identifying the cause of an overdose. They can enable timely intervention, reduce the risk of fatal outcomes, and open the door to substance use disorder treatment and recovery The post Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in…
